PROTOMER

In 2021, Protomer was acquired by Eli Lilly and Company. As a wholly-owned subsidiary, we've married the agility and audacity of a biotech startup with the history and impact of a global pharmaceutical company... Founded in 2015 and based in Pasadena, California, Protomer is engineering next-generation responsive biotherapeutics that can sense molecular activators in the body. The company's proprietary chemical biology-based Molecular Evolution of Peptide Sensors (MEPS) platform enables the development of therapeutic peptides and proteins with tunable activity that can be controlled using small molecules... At Protomer, we believe that the future of medicine lies in smarter medicines, so we built a company to invent them.

Also known as: Protomer Technologies, Protomer Technologies Inc.

Primary location: Pasadena United States